Geron Corporation (NASDAQ:GERN) shares are up 6.83% to $4.
In a research report released April 20, Oppenheimer analyst Ling Wang initiated coverage on shares of Agios Pharmaceuticals Inc (NASDAQ:AGIO), while no price target was …
In a research report issued today, MLV analyst Arlinda Lee maintained a Buy rating on Agios Pharmaceuticals Inc (NASDAQ:AGIO) with a price target …
Roth Capital’s healthcare analyst Debjit Chattopadhyay came out with a few comments on Agios Pharmaceuticals Inc (NASDAQ:AGIO), after the company reported a worse than expected fourth quarter results …